| Title | Photoallergic contact dermatitis from topical diclofenac in Solaraze gel. | | Author(s) | Kowalzick L, Ziegler H | | Institution | Klinik für Hautkrankheiten und Allergologie, HUMAINE Vogtland-Klinikum Plauen, Plauen, Germany. | | Source | Contact Dermatitis 2006 Jun; 54(6):348-9. | | Abstract | Solaraze((R)) gel (Shire Deutschland GmbH & Co. KG, Cologne, Germany) containing 3% diclofenac has been licensed in 2001 as a topical treatment for actinic keratoses. It is commonly used in dermatological practice. Undesirable effects are believed to be rare but include pruritus, paresthesia and application-site reactions (dry skin, rash, erythema, contact dermatitis and vesicobullous eruptions). Recently, a few cases of contact dermatitis due to three different allergens including diclofenac have been reported (1,2). | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 16787462 |
|
